Michael McDermott - 01 Jan 2022 Form 3 Insider Report for PFIZER INC (PFE)

Role
Executive Vice President
Signature
Susan E. Grant, by power of atty., for Michael McDermott
Issuer symbol
PFE
Transactions as of
01 Jan 2022
Net transactions value
$0
Form type
3
Filing time
10 Jan 2022, 08:15:20 UTC
Next filing
25 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PFE Common Stock 66,186 01 Jan 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding PFE Stock Appreciation Rights 01 Jan 2022 Common Stock 14,178 $22.89 Direct F1
holding PFE Stock Appreciation Rights 01 Jan 2022 Common Stock 12,340 $25.60 Direct F1
holding PFE Stock Appreciation Rights 01 Jan 2022 Common Stock 14,952 $27.34 Direct F2
holding PFE Stock Appreciation Rights 01 Jan 2022 Common Stock 12,412 $27.34 Direct F1
holding PFE Stock Appreciation Rights 01 Jan 2022 Common Stock 13,307 $30.17 Direct F2
holding PFE Stock Appreciation Rights 01 Jan 2022 Common Stock 11,125 $30.17 Direct F1
holding PFE Stock Appreciation Rights 01 Jan 2022 Common Stock 48,419 $31.31 Direct F2
holding PFE Stock Appreciation Rights 01 Jan 2022 Common Stock 41,485 $31.31 Direct F1
holding PFE Stock Appreciation Rights 01 Jan 2022 Common Stock 37,925 $33.82 Direct F2
holding PFE Stock Appreciation Rights 01 Jan 2022 Common Stock 32,769 $33.82 Direct F1
holding PFE Stock Appreciation Rights 01 Jan 2022 Common Stock 18,999 $38.71 Direct F2
holding PFE Stock Appreciation Rights 01 Jan 2022 Common Stock 16,011 $38.71 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.
F2 The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.

Remarks:

poamm21.htm